LD 1154 requires healthcare providers to inform women seeking an abortion for a fetus diagnosed with a lethal fetal anomaly (a condition likely to cause the baby's death within three months after birth) about perinatal hospice services as part of the informed consent process. Providers must discuss these services in person at least 24 hours before the procedure and provide a written list of available perinatal hospice providers, which the state will maintain. If the woman declines hospice services and chooses to proceed with the abortion, she must sign a written certification confirming her decision. This requirement does not apply in cases of medical emergencies or for abortions related to ectopic pregnancy or spontaneous miscarriage.
LD 1007 requires healthcare professionals in Maine to provide specific information during informed consent for drug-induced abortions. It mandates that providers inform patients about the potential for reversal if they change their mind (noting time sensitivity), and that initial studies suggest no increased maternal mortality or birth defect risks from reversal. Providers must also give patients a written statement with a website and helpline number (to be updated annually by the Department of Health) for information on abortion pill reversal services. This bill directly affects women seeking drug-induced abortions and their healthcare providers in Maine.
LD 1899 creates a new deduction for Maine state income tax on medical and dental expenses paid by taxpayers or their spouses/dependents. It allows a deduction for expenses that qualify under federal tax law (Internal Revenue Code), even if they don't meet the federal threshold or weren't claimed on federal returns. The deduction applies to expenses not covered by insurance and is effective for tax years beginning January 1, 2026. This directly affects individual Maine taxpayers who pay for healthcare costs, expanding their state tax relief beyond federal requirements.
LD 1712 amends Maine's Paid Family and Medical Leave program to adjust requirements for employees and employers. It requires employees to give reasonable notice before taking leave and allows employers to deny leave based on specific, defined hardships (such as having fewer than 15 employees, a summer labor shortage, or more than 25% of staff already on leave), without review of such decisions. The bill also revises benefit calculations to replace 65% of average weekly wage (with 90% replacement for wages up to 50% of the state average and 66% for higher wages), shortens application deadlines for benefits (with waivers for good cause), and modifies premium payments so employers deduct 50% of the cost from employee wages while covering the remaining 50%.
LD 544 exempts sales of cannabis for medical use from Maine's sales tax, creating tax parity with prescription medicines. The bill amends Maine's tax code to include medical cannabis sales (after January 1, 2026) under the existing exemption for prescription medicines sold by doctors. It directly affects patients certified for medical cannabis use under Maine's Medical Use of Cannabis Act and providers selling to them. This policy change removes a sales tax burden currently applied to medical cannabis, aligning its tax treatment with other prescribed medicines. The exemption applies only to cannabis sold with a medical provider's certification, not recreational sales.
LD 1333 updates Maine's Paid Family and Medical Leave program to clarify eligibility and administration. It requires employees to have worked for an employer for at least 120 days to qualify, shortens the deadline for filing leave applications from 90 to 30 days after leave begins, and adjusts employer contribution rules: companies with 15+ workers can deduct 50% of premiums from employee wages and send 100% to the fund, while smaller employers send 50%. The bill also specifies that leave under this program runs concurrently with federal FMLA, and defines "self-employed" to include small business owners with fewer than 15 employees. These changes directly affect Maine workers seeking leave and their employers managing contributions.
LD 189 removes the requirement for health care facilities to obtain state approval (a "certificate of need") before offering mental health services or substance use disorder treatment in Maine. This change directly affects facilities providing these services, allowing them to expand or start new programs without waiting for state review. By eliminating this regulatory barrier, the bill aims to increase the availability and affordability of mental health and substance use disorder care for residents. The legislation amends Maine law to specifically exclude these services from the certificate of need process.
LD 633 requires Maine's investor-owned utilities to include in their emergency response plans procedures for identifying customers with a documented need for electricity to power essential medical equipment, such as ventilators, oxygen concentrators, or dialysis machines. The bill mandates that utilities develop documented outreach plans to contact these medically vulnerable individuals during power outages. This ensures timely communication and support for patients whose health depends on uninterrupted power for critical devices. The bill directly affects utilities and the approximately 1,000+ Maine residents relying on such equipment, as defined in the legislation.
This bill corrects a drafting error in a 2023 law that unintentionally applied to all air ambulance providers. It clarifies that health insurance carriers cannot require prior authorization for air ambulance transport only when the service provider is a nonprofit organization. The law specifically applies to nonprofits transporting patients to or between hospitals for urgent care, as defined in Maine law. The correction is retroactive to August 9, 2024, the effective date of the original 2023 law.
